Delivery Order SPE2DB20D9759-SPE2DB25FD5NN

Award Date 5/12/25
Potential Completion Date 6/3/25
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,544.44, is for the supply of the pharmaceutical product Lucentis 0.5 mg/0.05 ml syringe 0.05 ml. DMS Pharmaceutical Group holds a significant single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,861.10, is for the provision of LUCENTIS 0.5 MG/0.05 ML SYRING 0.05ML, a specialized pharmaceutical product. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order (SPE2DX24F5ZZU) valued at $11,583.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide Lucentis 0.5 mg/0.05 ml syringes. This delivery order is part of a larger indefinite delivery contract (SPE2DB), valued up to $499,999,999, that DMS Pharmaceutical Group holds with the DLA to supply a comprehensive range of pharmaceutical products to support the recurring medical...
This is a delivery order (SPE2DB20D9759|SPE2DB24FD5MT) awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) for the supply of Lucentis 0.5 mg/0.05 ml syringes. The $4,633.32 firm fixed-price contract has a completion date of September 25, 2024. DMS Pharmaceutical Group is a key supplier to the Department of Defense (DoD) and Department of Veterans Affairs (VA) medical facilities, providing a wide range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,861.10, is for the delivery of LUCENTIS 0.5 MG/0.05 ML SYRING 0.05ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a performance period through May 29, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $5,059.60 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for 0.3 mg/0.05 mL syringes of Lucentis, a branded ophthalmic pharmaceutical product. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB24FB3JY, with a ceiling of up to $4,999,999 that enables DLA to issue delivery orders for a variety of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,544.44, is for the delivery of Lucentis 0.5 mg/0.05 ml syringes to support the medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,633.32 contract is for the delivery of Lucentis 0.5 mg/0.05 ml, a prescription medication, to support the medical supply needs of military health facilities. This delivery order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business based in Park Ridge, Illinois. The $15,444.40 contract is for the delivery of LUCENTIS 0.5 MG/0.05 ML SYRING 0.05ML, a pharmaceutical product, by March 12, 2024. DMS Pharmaceutical Group holds a broader indefinite delivery contract with the DLA, valued up to $4,999,999 through 2025, to provide a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,544.44 firm fixed-price delivery order is for the supply of LUCENTIS 0.5 MG/0.05 ML syringes, with a completion date of October 8, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
  • SPE2DB20D9759
    Indefinite Delivery Contract
  • SPE2DB20D9759-SPE2DB25FD5NN
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $4,510.28 contract is for the supply of 0.3 mg/0.05 ml Lucentis syringes. The order has a completion date of June 3, 2025.

DMS Pharmaceutical Group is a pharmaceutical wholesaler that specializes in providing a range of medical products, including prescription drugs, biologics, and consumables, to federal agencies. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999, which allows the agency to issue delivery orders for various pharmaceutical items to support the medical supply needs of military health facilities.

This contract award does not have a set-aside designation, but DMS Pharmaceutical Group's status as a woman-owned small business allows it to compete effectively in federal procurement markets.

Generated 8/17/25, 12:49 AM